Back to all issues
Issue #13
October 14, 2025

MRI innovation halves scan time for whole-brain imaging

PLUS: Dana-Farber experts urge FDA to strengthen radiology AI standards

RadAI Slice Newsletter

Weekly Updates in Radiology AI

Good morning, there. A motion-robust MRI method achieved 180μm whole-brain imaging in 17 minutes.

I am impressed by a multicenter team that reduced high-res neuro MRI scan time from 34 to 17 minutes. This supports broader use of mesoscale neuroimaging and minimizes motion artifacts. The technique could make advanced brain MR more accessible for research and clinics alike.

How would faster, motion-resilient MRI impact your neuroimaging workflow?


Here's what you need to know about Radiology AI last week:

  • Mesoscale MRI Doubles Speed for Motion-Robust Brain Imaging

  • Calls Grow for Stronger FDA Evidence Standards in Radiology AI

  • First FDA-Cleared AI for Mitral Annular Calcification on Routine CT

  • Commercial AI for Fracture Detection: Real-World Prospective Study

  • Plus: 4 newly released datasets, 6 FDA approved devices & 4 new papers.

🧾 NEW WEBSITE FEATURE

You can now filter our FDA device database by regulatory pathway, review panel, and product code.

Explore FDA AI devices →

LATEST DEVELOPMENTS

🧠 Mesoscale MRI Doubles Speed for Motion-Robust Brain Imaging

RadAI Slice: A new neural network-based MRI method reduces scan time for high-res whole-brain imaging.

The details:

  • Delivers 180μm isotropic T2 MRI in just 17 minutes at 7T

  • Yields 22% lower reconstruction error than standard approaches

  • Validated in both ex vivo and in vivo datasets with real motion

  • Enables sharper, faster imaging for advanced neuro research

Key takeaway: Advanced neural-MRI workflows could become more efficient and motion-tolerant, bringing high-res imaging into routine research and eventually clinical settings.

💡 Calls Grow for Stronger FDA Evidence Standards in Radiology AI

RadAI Slice: A Dana-Farber review urges the FDA to adopt stricter, more transparent AI validation rules.

The details:

  • Retrospective-only validation is routine for most AI tools now

  • Experts seek more real-world, reader, and prospective studies

  • Synthetic data use in FDA clearance is questioned in some cases

  • Public validation database and reporting checklists recommended

Key takeaway: Clearer FDA standards could help drive trustworthy, clinically relevant AI—raising the quality bar for validated radiology tools and increasing patient safety.

🫀 First FDA-Cleared AI for Mitral Annular Calcification on Routine CT

🫀 First FDA-Cleared AI for Mitral Annular Calcification on Routine CT

Image from: Cardiovascular Business

RadAI Slice: Mitral annular calcification (MAC) AI is now FDA-cleared for non-gated routine CT scans.

The details:

  • Works across a broad range of routine CT protocols

  • First FDA-approved tool specific to MAC detection

  • Development included data from over 25 major centers

  • May boost detection of at-risk cardiovascular patients

Key takeaway: Routine CT scans can now consistently screen for MAC, enabling improved risk assessment during standard imaging and supporting heart disease management.

🦴 Commercial AI for Fracture Detection: Real-World Prospective Study

RadAI Slice: A large prospective study benchmarked three x-ray AI tools across 1,037 adults and 22 regions.

The details:

  • Rayvolve AUC: 84.9%; BoneView: 84%; RBFracture: 77.2%

  • Highest sensitivity: Rayvolve at 79.5%

  • Multiple fractures remain a challenging scenario for all tools

  • AI shown to work best as an adjunct, not a replacement

Key takeaway: Radiology AI tools show real utility—but limitations for complex or multiple injuries reinforce the need for expert oversight and continued multicenter validation.

NEW DATASETS

RadGenome-Chest CT (2025)

Modality: CT | Focus: chest, lung | Task: report generation, VQA

  • Size: 25,692 CT volumes from 21,304 patients

  • Annotations: 197-region segmentation masks, region-grounded report sentences, 1.2M region-linked VQA pairs

  • Institutions: Shanghai Jiao Tong University, Shanghai AI Laboratory et al.

  • Availability:

    public (link)

  • Highlight: First large-scale, region-grounded vision-language dataset for 3D chest CT; supports multimodal foundation model benchmarking

BIND (2025-10-02)

Modality: MRI, CT | Focus: Brain, neurophysiology | Task: Classification, segmentation

  • Size: 1.8M scans from 38,945 patients

  • Annotations: Structured pathology labels from clinical reports (LLM-extracted); session-level reports; some sequence segmentations

  • Institutions: Massachusetts General Hospital, Stanford University, et al.

  • Availability:

  • Highlight: Largest multimodal brain imaging and neurophysiology dataset; integrated with EEG/PSG; LLM-extracted structured clinical findings

BreastDCEDL AMBL (2025-10-04)

Modality: MRI | Focus: Breast | Task: Classification, Segmentation

  • Size: 133 annotated lesions (89 benign, 44 malignant) from 88 patients

  • Annotations: Manual segmentations for benign and malignant lesions, lesion-level masks in 3D NIfTI format

  • Institutions: Ariel University, The Cancer Imaging Archive

  • Availability:

    public (Zenodo link)

  • Highlight: First public DCE-MRI dataset with both benign and malignant breast lesion annotations for reproducible AI benchmarking

SpineMed-450k (2025-10-03)

Modality: CT, MRI, X-ray | Focus: Spine, Orthopedics | Task: QA, report generation

  • Size: ~33,000 images, 834 hospital cases, 463k QA pairs, ~1,000 patients

  • Annotations: Multiple-choice/open-ended QA, reports, dialogue, precise vertebral-level reasoning

  • Institutions: Jilin University, Nanjing University, et al.

  • Availability:

    Request-only (project page or contact authors, full dataset not directly public as of paper date)

  • Highlight: Largest multimodal, level-aware, traceable spine AI dataset; integrates real hospital cases and clinician-in-the-loop curation.

QUICK HITS

🏛️ FDA Clearances

  • K250662 - Bunkerhill MAC (BunkerHill Health): FDA-cleared tool for mitral annular calcification on routine CT, aiding broad-scale cardiovascular risk detection.

  • K250766 - LungQ 4 (Thirona BV): CT-based product supports lung analysis with AI-driven insights for diagnostic workflows.

  • K251215 - Philips IntelliSpace Cardiovascular: Multimodal cardiovascular image suite for clinical diagnosis and treatment planning.

  • K251859 - Olympus EVIS EUS Ultrasound GI Videoscope: Advanced endoscopic ultrasound for gastrointestinal assessment.

  • K250039 - HPACS (HealthHub): Radiology imaging platform enhances and manages images for workflow efficiency.

  • K250026 - Shear Wave Quantificational Ultrasound (Wuxi Hisky): Provides quant tissue stiffness from ultrasound, aiding diagnosis and treatment guidance.

📄 Fresh Papers

  • doi:10.1183/13993003.00933-2025 - A multinational, prospective ARDS cohort identifies three distinct CT proteomic phenotypes with different treatment responses and outcomes.

  • doi:10.1016/j.jacr.2025.09.032 - A practical four-phase framework is proposed for radiology AI deployment: validation, implementation, value assessment, and post-market surveillance.

  • doi:10.1016/j.acra.2025.09.018 - Prospective dual-center study shows deep learning-based ultra-low-dose CTPA, aided by AI, sustains high PE diagnostic accuracy with 74% dose reduction.

  • doi:10.3174/ajnr.A8977 - Motion-informed deep learning improves 3D brain MRI image quality and morphometric accuracy in cognitively impaired patients.

  • Browse 200 new radiology AI studies from last week.

📰 Everything else in Radiology AI last week

That's it for today!

Before you go we’d love to know what you thought of today's newsletter to help us improve the RadAI Slice experience for you.

⭐⭐⭐⭐⭐ Nailed it
⭐⭐⭐ Average
⭐ Fail

👋 Quick favor: drag this into your Primary tab so you don’t miss next week. Or just hit Reply with one thought.

See you next week.


P.S. I’m building a reader-curated list of radiology AI tools. which one would you nominate?

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.